Global Shortage In Cytology Behind Backlog of 78,000 Cervical Tests

Cervical Smear Tests are essential to rule out cervical cancer resulting from cervical erosion. A well-known etiology of cervical cancer is HPV infection, which is one of the most common sexually transmitted viruses. Timely diagnosis is crucial to improve the disease prognosis.Cervix Uterus

CervicalCheck is the Irish national cervical screening program that provides screening services to women from the ages of 25 to 60. The samples are taken from the patient and sent to the national laboratories for testing.

In the past year, there have been reports of delayed results of cervical smears in thousands of women. Some delays even took up to 27 weeks. Currently, there is a backlog of 78,000 slides from women who had smear tests done at CervicalCheck.

Statement from CervicalCheck

The CervicalCheck officials must appear before the Oireachtas Health Committee to explain the reasons behind the delay, and also provide an update on the progression of the controversy that began months ago.

According to Damien McCallion, national director of screening services, he will inform the committee that it is difficult to find laboratories to clear as the task “has proved very challenging due to the global shortage in cytology”.

“This has been caused as a result of the reduced cytology requirement as countries implement HPV primary screening – which sees a reduction of around 80pc for cytology requirements. We are actively trying to identify possible solutions that will help reduce the wait times which we know are causing a lot of anxiety for women,” said McCallion.

How is the issue being dealt with?

To combat the issue, McCallion will state “a new client services unit was set up in the national screening service to support the release of medical records and slides to women. Some 109 of the 118 slide requests have been dealt with in an average of 25 days and there are only nine requests still being processed.”

McCallion also added that a project team has been assigned to add HPV testing of cervical smears, which will reduce the chances of abnormalities being missed.
With an aim to introduce HPV testing to cervical smear, and solve the backlog controversy, CervicalCheck has also appointed new staff.


Ongoing backlog of 78,000 smear tests ‘hindered by lab shortage’

Articles you may like:

Vaccination Rates below 90% Could Paradoxically Promote the Emergence of Resistant Variants

Nightmare Scenario: Could the Current Poorly Implemented Vaccination Campaign Lead to More Deadly SARS-CoV-2 Strains

Diets High in Plant Proteins Protect Women from Dementia, Cardiovascular Disease, and Cancer

Drinking Too Much Coffee Can Reduce Brain Size, and Cause Dementia

A New Cause of Male Infertility Found: Spermatozoa Swimming in Circles

Possible Causes of the Sudden Fall In COVID-19 Infections in the UK and Europe

SARS-CoV-2 Transmissibility: Can You Really Catch COVID-19 through Flatulence (Farts)?

MIT: A Once a Month Contraceptive Pill Could Soon Become Reality

Moderna and Pfizer’s mRNA Vaccines Do Not Make Straight Men Gay

Researchers to Start Testing Male Contraceptive Gel

Gilmore Health News

Coronavirus: The Real and False Side Effects of COVID-19 Vaccines

Guillain-Barré Syndrome Observed after the First Dose of the AstraZeneca Vaccine


Genf20 Plus: Reviews, Cost, Benefits, Ingredients, Side Effects, and Testimonials




Want to Stay Informed?

Join the Gilmore Health News Newsletter!

Want to live your best life?

Get the Gilmore Health Weekly newsletter for health tips, wellness updates and more.

By clicking "Subscribe," I agree to the Gilmore Health and . I also agree to receive emails from Gilmore Health and I understand that I may opt out of Gilmore Health subscriptions at any time.